The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Monkeypox Vaccine Market Research Report 2025
Synopsis
Monkeypox is a viral zoonosis (a virus transmitted to humans from animals) with symptoms very similar to those seen in the past in smallpox patients, although it is clinically less severe. With the eradication of smallpox in 1980 and subsequent cessation of smallpox vaccination, monkeypox has emerged as the most important orthopoxvirus for public health. Monkeypox primarily occurs in Central and West Africa, often in proximity to tropical rainforests and has been increasingly appearing in urban areas. Animal hosts include a range of rodents and non-human primates.
Global Monkeypox Vaccine market is projected to reach US$ 10 million in 2029, increasing from US$ 5 million in 2022, with the CAGR of 5.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Monkeypox Vaccine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Monkeypox Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bavarian Nordic inks
Segment by Type
DNA
Non-replicating Viral Vector
Protein Subunit
RNA
Others
Segment by Application
Aldult
Child
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Monkeypox Vaccine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Monkeypox is a viral zoonosis (a virus transmitted to humans from animals) with symptoms very similar to those seen in the past in smallpox patients, although it is clinically less severe. With the eradication of smallpox in 1980 and subsequent cessation of smallpox vaccination, monkeypox has emerged as the most important orthopoxvirus for public health. Monkeypox primarily occurs in Central and West Africa, often in proximity to tropical rainforests and has been increasingly appearing in urban areas. Animal hosts include a range of rodents and non-human primates.
Global Monkeypox Vaccine market is projected to reach US$ 10 million in 2029, increasing from US$ 5 million in 2022, with the CAGR of 5.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Monkeypox Vaccine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Monkeypox Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bavarian Nordic inks
Segment by Type
DNA
Non-replicating Viral Vector
Protein Subunit
RNA
Others
Segment by Application
Aldult
Child
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Monkeypox Vaccine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Monkeypox Vaccine Market Overview
1.1 Product Overview and Scope of Monkeypox Vaccine
1.2 Monkeypox Vaccine Segment by Type
1.2.1 Global Monkeypox Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 DNA
1.2.3 Non-replicating Viral Vector
1.2.4 Protein Subunit
1.2.5 RNA
1.2.6 Others
1.3 Monkeypox Vaccine Segment by Application
1.3.1 Global Monkeypox Vaccine Market Value by Application: (2023-2029)
1.3.2 Aldult
1.3.3 Child
1.4 Global Monkeypox Vaccine Market Size Estimates and Forecasts
1.4.1 Global Monkeypox Vaccine Revenue 2018-2029
1.4.2 Global Monkeypox Vaccine Sales 2018-2029
1.4.3 Global Monkeypox Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Monkeypox Vaccine Market Competition by Manufacturers
2.1 Global Monkeypox Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Monkeypox Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Monkeypox Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Monkeypox Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Monkeypox Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Monkeypox Vaccine, Product Type & Application
2.7 Monkeypox Vaccine Market Competitive Situation and Trends
2.7.1 Monkeypox Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Monkeypox Vaccine Players Market Share by Revenue
2.7.3 Global Monkeypox Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Monkeypox Vaccine Retrospective Market Scenario by Region
3.1 Global Monkeypox Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Monkeypox Vaccine Global Monkeypox Vaccine Sales by Region: 2018-2029
3.2.1 Global Monkeypox Vaccine Sales by Region: 2018-2023
3.2.2 Global Monkeypox Vaccine Sales by Region: 2024-2029
3.3 Global Monkeypox Vaccine Global Monkeypox Vaccine Revenue by Region: 2018-2029
3.3.1 Global Monkeypox Vaccine Revenue by Region: 2018-2023
3.3.2 Global Monkeypox Vaccine Revenue by Region: 2024-2029
3.4 North America Monkeypox Vaccine Market Facts & Figures by Country
3.4.1 North America Monkeypox Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Monkeypox Vaccine Sales by Country (2018-2029)
3.4.3 North America Monkeypox Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Monkeypox Vaccine Market Facts & Figures by Country
3.5.1 Europe Monkeypox Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Monkeypox Vaccine Sales by Country (2018-2029)
3.5.3 Europe Monkeypox Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Monkeypox Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Monkeypox Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Monkeypox Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Monkeypox Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Monkeypox Vaccine Market Facts & Figures by Country
3.7.1 Latin America Monkeypox Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Monkeypox Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Monkeypox Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Monkeypox Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Monkeypox Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Monkeypox Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Monkeypox Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Monkeypox Vaccine Sales by Type (2018-2029)
4.1.1 Global Monkeypox Vaccine Sales by Type (2018-2023)
4.1.2 Global Monkeypox Vaccine Sales by Type (2024-2029)
4.1.3 Global Monkeypox Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Monkeypox Vaccine Revenue by Type (2018-2029)
4.2.1 Global Monkeypox Vaccine Revenue by Type (2018-2023)
4.2.2 Global Monkeypox Vaccine Revenue by Type (2024-2029)
4.2.3 Global Monkeypox Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Monkeypox Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Monkeypox Vaccine Sales by Application (2018-2029)
5.1.1 Global Monkeypox Vaccine Sales by Application (2018-2023)
5.1.2 Global Monkeypox Vaccine Sales by Application (2024-2029)
5.1.3 Global Monkeypox Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Monkeypox Vaccine Revenue by Application (2018-2029)
5.2.1 Global Monkeypox Vaccine Revenue by Application (2018-2023)
5.2.2 Global Monkeypox Vaccine Revenue by Application (2024-2029)
5.2.3 Global Monkeypox Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Monkeypox Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Bavarian Nordic inks
6.1.1 Bavarian Nordic inks Corporation Information
6.1.2 Bavarian Nordic inks Description and Business Overview
6.1.3 Bavarian Nordic inks Monkeypox Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Bavarian Nordic inks Monkeypox Vaccine Product Portfolio
6.1.5 Bavarian Nordic inks Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Monkeypox Vaccine Industry Chain Analysis
7.2 Monkeypox Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Monkeypox Vaccine Production Mode & Process
7.4 Monkeypox Vaccine Sales and Marketing
7.4.1 Monkeypox Vaccine Sales Channels
7.4.2 Monkeypox Vaccine Distributors
7.5 Monkeypox Vaccine Customers
8 Monkeypox Vaccine Market Dynamics
8.1 Monkeypox Vaccine Industry Trends
8.2 Monkeypox Vaccine Market Drivers
8.3 Monkeypox Vaccine Market Challenges
8.4 Monkeypox Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
